Partnering & Outsourcing Editorial

  1. Getting A Grasp On CRO Selection 6/25/2024

    Companies can spend a great deal of time negotiating preferred provider agreements (PPAs), and their presence, or lack thereof, can make or break which CROs are shortlisted or awarded a Phase II/III study.

  2. Storyboarding: The Secret Weapon Of GCP Quality Assurance 6/6/2024

    Discover how storyboards in GCP quality assurance can serve as a framework for crafting clear, consistent messaging that resonates across inspection teams with GCP consultant Donatella Ballerini.

  3. Is Your Intellectual Property Safe With Indian CROs And CDMOs? 6/3/2024

    Startups and Big Pharma companies alike are considering India as an alternative to working with China. Is it safe to do business with India? Let's do a deep dive, with insights from American and Indian attorneys.

  4. Reeve Foundation Advances SCI Trials And Treatments With Symposium, Partnerships 5/28/2024

    Reeve Foundation CSO Mario Baptista, Ph.D., delves into the current landscape of SCI clinical trials, exploring the challenges that continue to impede progress and the strategies being employed to overcome them.

  5. Clinical Outsourcing Observations And Predictions 5/22/2024

    Industry expert Samir Shah talks about why the FSP model is so popular these days and how site networks could become a replacement for CROs in some situations. He also suggests a new type of contracting model that could save sponsors and sites money.

  6. The Best Advice I Ever Got: On The Job 5/22/2024

    To commemorate Clinical Trials Day 2024, Clinical Leader tapped its community of clinical research professionals to share their insights — from individual efforts to partnership best practices to trial design and more.

  7. The Best Advice I Ever Got: Networking 5/20/2024

    To commemorate Clinical Trials Day 2024, Clinical Leader tapped its community of clinical research professionals to share their experiences with and praise for working with one another across the industry.

  8. Multidisciplinary Collaborations Fuel New Glioma Treatment Breakthroughs 5/6/2024

    Servier's Susan Pandya, MD, vice president of clinical development, shares what can be achieved when scientists, patients, investigators, and advocacy groups collaborate to create an innovative trial design for a potential breakthrough therapy.

  9. Fortifying The 3 Cs With Strategic Approaches And Tools 4/25/2024

    In part two of this series, the authors continue the discussion by identifying specific tools and strategies that companies can use to improve communication and collaboration.

  10. Looking Back & Moving Forward With J&J's Global Development Leader For Immunology 4/15/2024

    In this Q&A, David Gordon, M.B., Ch.B. recounts lessons learned from past clinical trial challenges and shares current-day strategies, like figuring out how to run a study that’s both scientifically sound and actually doable for patients and doctors.